AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 287: E63-E68, 2004. First published February 17, 2004; doi:10.1152/ajpendo.00375.2003
0193-1849/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/1/E63    most recent
00375.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buijs, M. M.
Right arrow Articles by Pijl, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buijs, M. M.
Right arrow Articles by Pijl, H.

Glucose homeostasis in abdominal obesity: hepatic hyperresponsiveness to growth hormone action

M. M. Buijs,1 J. A. Romijn,2 J. Burggraaf,3 M. L. de Kam,3 M. Frölich,1 M. T. Ackermans,4 H. P. Sauerwein,5 A. F. Cohen,3 A. E. Meinders,1 and H. Pijl1

Departments of 1General Internal Medicine and 2Endocrinology, and 3Center for Human Drug Research, Leiden University Medical Center, 2300 RC Leiden; and 4Department of Clinical Chemistry, Laboratory of Endocrinology and Radiochemistry, and 5Department of Endocrinology and Metabolism, Academic Medical Center, 1100 DD Amsterdam, The Netherlands

Submitted 20 August 2003 ; accepted in final form 16 February 2004

It has been suggested that (abdominally) obese individuals are hypersensitive to growth hormone (GH) action. Because GH affects glucose metabolism, this may impact glucose homeostasis in abdominal obesity. Therefore, we studied the effect of GH on glucose metabolism in abdominally obese (OB) and normal-weight (NW) premenopausal women. A 1-h intravenous infusion of GH or placebo was randomly administered to six NW [body mass index (BMI) 21.1 ± 1.9 kg/m2] and six OB (BMI 35.5 ± 1.5 kg/m2) women in a crossover design. Insulin, glucagon, and GH secretion were suppressed by concomitant infusion of somatostatin. Glucose kinetics were measured using a 10-h infusion of [6,6-2H2]glucose. In both groups, similar physiological GH peaks were reached by infusion of GH. GH strongly stimulated endogenous glucose production (EGP) in both groups. The percent increase was significantly greater in OB than in NW women (29.8 ± 11.3 vs. 13.3 ± 7.4%, P = 0.014). Accordingly, GH responsiveness, defined as the maximum response of EGP per unit GH, was increased in OB vs. NW subjects (6.0 ± 2.1 vs. 2.2 ± 1.5 µmol·min–1·mU–1·l–1, P = 0.006). These results suggest that the liver is hyperresponsive to GH action in abdominally obese women. The role of the somatotropic ensemble in the control of glucose homeostasis in abdominal obesity is discussed.

hyperinsulinemia; hyposomatotropism; glucagon



Address for reprint requests and other correspondence: H. Pijl, Dept. of General Internal Medicine, Leiden Univ. Medical Center, C1-R39, PO Box 9600, 2300 RC Leiden, The Netherlands (E-mail:h.pijl{at}lumc.nl).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.